AGM Presentation
22 November 2017 | PGC.ASX
A low-risk exposure to a rapidly growing health care company
Company highlights
FY17 Results Summary & Overview
FY18 guidance and Seasonality
Operational updates
Vision and strategy
Appendix:
Corporate Overview
Paragon is one of the premier medical equipment, device and consumables suppliers on the ASX
Platform economics, valuable distribution networks and a customer-centric business model all differentiate Paragon's service offering
Favourable macro tailwinds given the ageing population and increasing investment in health care
Well-capitalised balance sheet to pursue additional growth opportunities, with a conservative approach to debt finance and ability to use scrip for acquisitions
Highly aligned Board and management team with supportive institutional shareholder base
Shareholder returns will continue to be driven by strong growth in earnings, targeting $250 million in revenue, which supports increasing fully franked dividends to shareholders
14 value accretive acquisitions over the last 8 years have supported strong organic and inorganic growth in a highly fragmented industry
Record FY17 full year results reflect another strong year of growth with positive outlook for FY18
Revenue
$117.2m
2016: $93.4m up 25%
Net profit after tax
$10.2m
2016: $7.5m up 35%
Operating cash flow
$12.0m
2016: $7.8m up 54%
Gross profit
$46.1m
2016: $36.5m up 26%
EBITDA
$17.1m
2016: $12.1m up 41%
Earnings per share
6.2c
2016: 5.6c up 11%
Dividend per share
1.9c ff
2016: 1.4c up 36%
Cash balance
$18.6m
2016: $19.1m
Net Debt/EBITDA
1.1x
2016: 1.6x down 31%
Paragon Care Ltd. published this content on 23 November 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 November 2017 05:31:07 UTC.
Original documenthttps://www.paragoncare.com.au/wp-content/uploads/PGC_2017-AGM-Presentation-2017-11-22.pdf
Public permalinkhttp://www.publicnow.com/view/0E766C7B43E82403F35FCD07D56E1BAFBBA5D189